Liping Yang

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Emerging roles of SIRT6 and its modulators in kidney diseases.

Emerging roles of SIRT6 and its modulators in kidney diseases.

Journal: Cell death discovery

Published: April 08, 2026

Mitigation of renal tubular injury by SIRT6 may improve individual outcomes in diabetic kidney disease-potential mechanisms involving epigenetic repression of inflammatory responses.

Mitigation of renal tubular injury by SIRT6 may improve individual outcomes in diabetic kidney disease-potential mechanisms involving epigenetic repression of inflammatory responses.

Journal: Journal of advanced research

Published: June 27, 2025

Yiqi Qingre Gao alleviates renal fibrosis in UUO mice via PI3K/AKT pathway.

Yiqi Qingre Gao alleviates renal fibrosis in UUO mice via PI3K/AKT pathway.

Journal: Frontiers in pharmacology

Published: December 02, 2024

Exploring the Prognostic Value of Tumour-Associated Genes in Clear Cell Renal Cell Carcinoma Through Single-Cell RNA Sequencing Insights.

Exploring the Prognostic Value of Tumour-Associated Genes in Clear Cell Renal Cell Carcinoma Through Single-Cell RNA Sequencing Insights.

Journal: Journal of cellular and molecular medicine

Published: September 17, 2024

Roles of Sirt1 and its modulators in diabetic microangiopathy: A review.

Roles of Sirt1 and its modulators in diabetic microangiopathy: A review.

Journal: International journal of biological macromolecules

Published: December 27, 2023

Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy.

Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy.

Journal: Journal of ethnopharmacology

Published: November 21, 2023

Serum high mobility group box 1 as a potential biomarker for the progression of kidney disease in patients with type 2 diabetes.

Serum high mobility group box 1 as a potential biomarker for the progression of kidney disease in patients with type 2 diabetes.

Journal: Frontiers in immunology

Published: November 06, 2023

Sirtuins in kidney diseases: potential mechanism and therapeutic targets.

Sirtuins in kidney diseases: potential mechanism and therapeutic targets.

Journal: Cell communication and signaling : CCS

Published: August 04, 2023

Targeting HMGB1: A Potential Therapeutic Strategy for Chronic Kidney Disease.

Targeting HMGB1: A Potential Therapeutic Strategy for Chronic Kidney Disease.

Journal: International journal of biological sciences

Published: July 10, 2023

Therapeutic application of traditional Chinese medicine in kidney disease: Sirtuins as potential targets.

Therapeutic application of traditional Chinese medicine in kidney disease: Sirtuins as potential targets.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: June 17, 2023

Knowledge landscapes and emerging trends of cardiorenal syndrome type 4: a bibliometrics and visual analysis from 2004 to 2022.

Knowledge landscapes and emerging trends of cardiorenal syndrome type 4: a bibliometrics and visual analysis from 2004 to 2022.

Journal: International urology and nephrology

Published: March 21, 2023

Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols.

Oxidative stress and inflammation in diabetic nephropathy: role of polyphenols.

Journal: Frontiers in immunology

Published: March 13, 2023

Showing 1-12 of 37

Last Updated: 09/26/2026